Metastatic breast cancer denotes distant organ involvement (e.g., liver, brain, bone) and typically changes therapeutic goals ...

After an aggressive breast cancer diagnosis, psychologist Loraine Alderman retires to bridge gaps in patient literature ...

PDS01ADC is a tumor-targeted IL-12 immunocytokine designed to activate the immune system directly within the tumor ...

In this segment, Dr. Morrison discusses the clinical evidence supporting subcutaneous immunotherapy and explains the concept ...

Dr. Sandy Srinivas explains how age, comorbidities and medications influence personalized prostate cancer treatment decisions ...

Fraser Symmans explains how ctDNA is replacing CTCs to monitor breast cancer, detect mutations and track minimal residual ...

MacDonald draws on her unique dual perspective to advocate for better patient education. Despite a decade of medical ...

Most surgical candidates, including many with prior thoracic or abdominal operations, can undergo minimally invasive ...

In this segment, Ms. Popolo discusses the practical and logistical differences between intravenous and subcutaneous ...

Receiving a diagnosis of stage 1 urothelial carcinoma (bladder cancer) can feel overwhelming, but at this stage, the cancer ...

Dr. Bizekis emphasized that ongoing heartburn should not be ignored. For patients with persistent reflux, speaking with a doctor and considering further evaluation, such as an endoscopy, can help ...

Attending meetings like the SGO Annual Meeting on Women's Cancer is driven by a shared commitment to patients and advancing ...